Accessibility Menu

Should You Forget IonQ and Buy These 2 Tech Stocks Instead?

UiPath and IBM could be better bets.

By Geoffrey Seiler Jan 18, 2026 at 10:30PM EST

Key Points

  • IonQ's trapped-ion technology has shown some nice advantages, but potential commercialization is many years away.
  • UiPath's agentic AI opportunity is much closer to a reality.
  • IBM, meanwhile, is a safer way to play quantum computing than IonQ.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.